The change of the quantitative HBsAg level during the natural course of chronic hepatitis B
Tóm tắt
Từ khóa
Tài liệu tham khảo
Fung, 2010, Hepatitis B virus DNA and hepatitis B surface antigen levels in chronic hepatitis B, Expert Rev Anti Infect Ther, 8, 717, 10.1586/eri.10.45
Lok, 2009, Chronic hepatitis B, update 2009, 50, 661
European Association for the Study of the Liver., 2009, EASL Clinical Practice Guidelines, management of chronic hepatitis B, 50, 227
Manesis, 2007, Prediction of treatment-related HBsAg loss in HBeAg-negative chronic hepatitis B, a clue from serum HBsAg levels, 12, 73
Tangkijvanich, 2009, Low pretreatment serum HBsAg level and viral mutations as predictors of response to PEG-interferon alpha-2b therapy in chronic hepatitis B, J Clin Virol, 46, 117, 10.1016/j.jcv.2009.07.005
Brunetto, 2009, Hepatitis B virus surface antigen levels, a guide to sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B, 49, 1141
Moucari, 2009, Early serum HBsAg drop, a strong predictor of sustained virological response to pegylated interferon alfa-2a in HBeAg-negative patients, 49, 1151
Jung, 2010, Change in serum hepatitis B surface antigen level and its clinical significance in treatment-naïve, hepatitis B e antigen-positive patients receiving entecavir, J Clin Gastroenterol, 44, 653, 10.1097/MCG.0b013e3181d52946
Jaroszewicz, 2010, Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV)-infection, a European perspective, 52, 514
Nguyen, 2010, Hepatitis B surface antigen levels during the natural history of chronic hepatitis B, a perspective on Asia, 52, 508
Thompson, 2010, Serum hepatitis B surface antigen and hepatitis B e antigen titers, disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers, 51, 1933
Song, 2005, Hepatitis B virus genotypes in Korea, an endemic area of hepatitis B virus infection, 48, 133
Cho, 2009, Distribution of hepatitis B virus genotypes in Korea, Korean J Hepatol, 15, 140, 10.3350/kjhep.2009.15.2.140
Lee, 2010, Long-term adefovir dipivoxil monotherapy for up to 5 years in lamivudine-resistant chronic hepatitis B, Antivir Ther, 15, 235, 10.3851/IMP1510
Deguchi, 2004, Quantitation of hepatitis B surface antigen by an automated chemiluminescent microparticle immunoassay, J Virol Methods, 115, 217, 10.1016/j.jviromet.2003.10.002
Nguyen, 2009, The role of quantitative hepatitis B serology in the natural history and management of chronic hepatitis B, Hepatol Int, 3, S5, 10.1007/s12072-009-9149-7
Yim, 2006, Natural history of chronic hepatitis B virus infection, what we knew in 1981 and what we know in 2005, 43, S173
Hadziyannis, 2001, Hepatitis B e antigen-negative chronic hepatitis B, Hepatology, 34, 617, 10.1053/jhep.2001.27834
Rodella, 2006, Quantitative analysis of HBsAg, IgM anti-HBc and anti-HBc avidity in acute and chronic hepatitis B, J Clin Virol, 37, 206, 10.1016/j.jcv.2006.06.011
Chan, 2007, Serum hepatitis B surface antigen quantitation can reflect hepatitis B virus in the liver and predict treatment response, Clin Gastroenterol Hepatol, 5, 1462, 10.1016/j.cgh.2007.09.005
Lu, 2008, Correlation between HBV cccDNA and HBsAg levels and their reduction by peginterferon alfa-2a based therapy in patients with chronic hepatitis B, Hepatology, 48, S746A
Manesis, 2008, HBsAg serum levels correlate with total liver HBV DNA but not with cccDNA, Hepatology, 48, S746A
Kohmoto, 2005, Quantitative detection of hepatitis B surface antigen by chemiluminescent microparticle immunoassay during lamivudine treatment of chronic hepatitis B virus carriers, J Med Virol, 75, 235, 10.1002/jmv.20262
Wiegand, 2008, A decline in hepatitis B virus surface antigen (HBsAg) predicts clearance, but does not correlate with quantitative hbeag or HBV DNA levels, Antivir Ther, 13, 547, 10.1177/135965350801300402
Kuhns, 2004, Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc, implications for future HBV screening policy, 44, 1332